Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Rheumatoid Arthritis
Location: United States, MD
A randomized , double-blind, placebo-controlled , multicenter, two-part, dose ranging and confirmatory study with an operationally seamless design, evaluating efficacy and safety of IL-6Ra mAb on top of methotrexate in patients with active rheumatoid arthritis who are inadequate responders of MTX therapy.
Do you have Rheumatoid arthritis? You may qualify to participate in a clinical research study.
IL-6Ra mAb is a randomized placebo controlled trial of an injectable IL-6Rmab for patient with active rheumatoid arthritis on methotrexate with active joint disease. There is 22 weeks of randomization followed by 58 weeks of open label extension.
CW ID: 169938
Date Last Changed:
July 23, 2013
The Center for Rheumatology and Bone Research2730 University Blvd West, Suite 306Wheaton, MD 20902Phone: 301 942-6610Fax: 301 942-7833
The Center for Rheumatology and Bone Research
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.